Human Longevity Inc. Adds PacBio(R) Sequencing to Enable Additional Insight...
Purchase of Two PacBio RS II Sequencing Systems Will Be Used to Help Build HLI’s Genotype/Phenotype Database
View ArticleHuman Longevity, Inc. Hires Industry Experts Barry Merriman, Ph.D., and Paul...
(LA JOLLA, CA) October 31, 2014—Human Longevity, Inc. (HLI), a biological data-driven human health technology and cell therapy company, today announced the addition of Barry Merriman, Ph.D., as Vice...
View ArticleHuman Longevity, Inc. Signs Collaborative Agreement with King’s College...
HLI Team and Professor Tim Spector, M.D., to Collaborate Using this Unique Registry of more than 11,000 well-Characterized Twins (LA JOLLA, CA) November 13, 2014—Human Longevity, Inc. (HLI), a...
View ArticlePersonal Genome Diagnostics, Inc. and Human Longevity, Inc. Sign Cancer...
HLI Licenses PGDx’s Suite of Cancer Solutions to Expand the Company’s Cancer Genomics Offering HLI to Perform Whole Genome Sequencing for PGDx BALTIMORE, MD, and LA JOLLA, CA, January 12, 2015 –...
View ArticleHuman Longevity, Inc. Signs Agreement with Genentech for Whole Genome...
(LA JOLLA, CA) January 14, 2015—Human Longevity, Inc. (HLI), the human health information technology and health care company, today announced a multi-year agreement with Genentech, a member of the...
View ArticleHuman Longevity, Inc. Receives CLIA Certification
(SAN DIEGO, CA) April 28, 2015 – Human Longevity, Inc. (HLI), the genomic-driven health information technology company, today announced that the company has received certification under the Clinical...
View ArticleHuman Longevity, Inc. and Cleveland Clinic Establish Broad Collaboration in...
Initial work will focus on Cleveland Clinic GeneBank study (LA JOLLA, CA and CLEVELAND, OH) May 14, 2015—Human Longevity, Inc. (HLI) and Cleveland Clinic today announced a broad collaboration agreement...
View ArticleHuman Longevity, Inc. Announces Research Fellows Program
Program Gives Experts from Several Disciplines Unique Opportunity to Advance Human Genomic Understanding Application Deadline is September 1, 2015 LA JOLLA, CA – Human Longevity, Inc. (HLI), the...
View ArticleHuman Longevity, Inc. Announces Kurt Oreshack as General Counsel
(SAN DIEGO, CA) July 8, 2015—Human Longevity, Inc. (HLI), the genomics based, technology driven company, announced today that Kurt Oreshack has been hired as General Counsel. With degrees in law and...
View ArticleHuman Longevity, Inc. Hires Life Sciences Leader, Mark Winham, as Chief...
(SAN DIEGO, CA) August 25, 2015—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today that Mark A. Winham has joined the company as Chief Operating Officer....
View ArticleHuman Longevity, Inc. and Discovery Ltd to Offer Whole Exome, Whole Genome...
HLI Introduces a Whole Exome Sequencing Product for $250 USD (SAN DIEGO, CA and SANDTON, SOUTH AFRICA)—September 22, 2015—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, and...
View ArticleHuman Longevity, Inc. Appoints William A. Roper, Jr. as Chief Financial Officer
(SAN DIEGO, CA) September 28, 2015—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today that William A. Roper, Jr. has been appointed Chief Financial Officer,...
View ArticleHuman Longevity, Inc. Launches the Health Nucleus, a Comprehensive and...
(SAN DIEGO, CA) OCTOBER 13, 2015 – Human Longevity, Inc. (HLI), the genomics-based, technology-driven company working to revolutionize the practice of medicine, announced today the launch of the...
View ArticleHuman Longevity, Inc. and Venter Institute Scientists Publish Paper...
Comparison of four common library prep methods found significant differences in types of microbes uncovered and showed biases in error and duplication rates (SAN DIEGO, CA)—October 26, 2015—Human...
View ArticleHuman Longevity, Inc. Hires Sally A. Howard as Head of Regulatory Affairs and...
(SAN DIEGO, CA) November 4, 2015—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today that Sally Howard, J.D., has been hired as Head of Regulatory Affairs and...
View ArticleHuman Longevity, Inc. (HLI) Acquires Cypher Genomics, Inc.
Cypher CEO, Ashley Van Zeeland, Ph.D. to become head of HLI’s Pediatric Business (SAN DIEGO, CA)—November 30, 2015—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced...
View ArticleHuman Longevity, Inc. (HLI) to Offer Oncology Products Including...
(SAN DIEGO, CA)—January 12, 2016—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today its oncology genomics program, including the development of comprehensive...
View ArticleHuman Longevity Inc. Advances Leadership Role in Newborn Genome Sequencing...
HLI to Offer Newborn Genome Sequencing Product in Combination with Stem Cell Banking (SAN DIEGO, CA)—January 28, 2016—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company,...
View ArticleHuman Longevity, Inc. (HLI) Hires Key Oncology Leader, Kenneth J. Bloom,...
Stephen P. Schoenberger, Ph.D., to head cancer vaccine program and Ezra Cohen, M.D. is staff oncologist (SAN DIEGO, CA)—February 3, 2016—Human Longevity, Inc. (HLI), the genomics-based,...
View ArticleHuman Longevity, Inc. Completes $220 Million Series B Financing
(SAN DIEGO, CA)—April 4, 2016—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today that the company has completed an offering of Series B Preferred Stock, raising...
View Article
